Document is current
Any future updates will be listed below
-
Authors
Nay, Mai-Anh https://orcid.org/0000-0002-6116-4987
Bisson, Alice
Auvet, Adrien
Delbove, Agathe
Berrouba, Aziz
Kamel, Toufik
Desgrouas, Maxime
Boulain, Thierry
- License Information
-
More Information
Article History
Received: 1 March 2025
Accepted: 15 June 2025
First Online: 8 July 2025
Declarations
:
: The study protocol was approved by the French Ethics Committee (Comité de Protection des Personnes—Ile de France VI—No. 22.00476.000051) on March 8, 2022, and enregistered at Clinicaltrials.gov (NCT05311007) and was conducted in compliance with the latest version of the Declaration of Helsinki and good clinical practice guidelines. Patients, or, if they were unable to provide consent, their next of kin gave oral informed consent.
: Not applicable.
: MAN reports receiving remuneration for presentations, fundings and material support from Fisher & Paykel healthcare and travel and congress fees from Pfizer. However, Fisher & Paykel healthcare was not involved in the development, writing, or submission of the present manuscript. The other authors declared no conflicts of interest.
